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  Abstract  
Tapak liman (Elephantopus scaber L) is one of the traditional medicinal plants, which are containing several active com-
pounds that potentially affecting hematopoietic. The aims of this study are to elucidate the effect of leaf extract of Ta-
pak Liman on hematopoietic in mice BALB/c, by observation on relative number of cells expressing CD4/CD8, 
CD4/CD62L, and TER119/B220 in the spleen; TER119/B220, TER119/VLA-4 and TER119/CD34 in bone marrow, after 
given the leaf extract for 2 weeks. This experiment was used 12 female mice, which is divided on 3group treated with 
leaf extract of Tapak Liman (P1= 0.5 g. g bw
-1
.day
-1
, P2= 1.0 g. g bw
-1
.day
-1
 and P3 = 2.0 g. g bw
-1
.day
-1
) and control. The 
relative numbers of cells expressing surface molecules were analyzed by flowcytometry and quantitative data were 
tested using one way ANOVA. The result showed the leaf extract of Tapak Liman has no significant effect on erythrocyte 
proliferation, on the other hand it have significant effect on both proliferation and differentiation of B lymphocytes 
(B220
+
) in the bone marrow (p=0.044) and increase the expression of CD4
+
, CD8
+
molecule in B cells (p=0.026) and ery-
troid (TER119
+
VLA-4
+
) in spleen and bone marrow. The administration of 1 g. g bw
-1
.day
-1 
of the extract (P2) stimulate 
proliferation of lymphocytes and erythrocytes lineage (TER119
+
VLA-4
+
), in spleen and bone marrow. 
  
Keywords: CD4
+
, CD8
+
, Elephantopus scaber, erythrocyte, hematopoiesis.  
 
 
INTRODUCTION 
Tapak liman (Elephantopus scaber L) is one of 
the traditional medicinal plants that has been 
known for centuries, especially among pharma-
cologists in China. Tapak liman contain 
epifrieelinol, lupeol, stigmasterol, triacontan-1-ol, 
dotriacontan-1-ol, lupeol acetate, deoxyelephan-
topin, isodeoxyelephantopin, flavonoid, polyphe-
nol luteolin-7, and glucoside. Tapak liman is used 
as a traditional medicine in the form of fresh, 
dried, even extracted and put into capsules. 
Types of diseases that can be treated with Tapak 
Liman include various inflammatory diseases 
such as inflammation of the tonsils, influenza, 
sore throat, eye inflammation, kidney inflamma-
tion, acute and chronic inflammation of the ute-
rus or vaginal discharge. Additionally, Tapak Li-
man also serves as a laxative of urine, decrease 
fever, clear phlegm, antioxidants, and blood 
booster. It is also useful to overcome the chicken 
pox and anemia [1].  
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Anemia is a disease in deficiency of red cell 
volume and hemoglobin levels (Hb) thus the 
body will have hypoxia as a result of reduced 
oxygen-carrying capacity capabilities [2]. Anemia 
can be caused by autoimmune diseases such as 
hemolytic and aplastic anemia due to delays in 
the process of erythropoiesis [3]. Until now, the 
treatment of anemia that caused by erythropoie-
sis barriers solely depends on the provision of 
artificial hematopoietin commonly is called the 
ESA (Erythropoiesis Stimulating Agent), a synthet-
ic compound that can stimulate the production 
of blood cells. However, the ESA has harmful side 
effects to the user's health such as cardiovascular 
complications [4] and retinopathy [5]. It provides 
an opportunity to investigate and search for 
compounds that could stimulate and affect eryt-
hropoiesis as a safe anemia drug ingredient, with 
no side effects, and keep the immune system in 
which a chemical compound has the potential to 
induce the process of proliferation and differen-
tiation of erythropoiesis and lymphopoiesis. 
Based on the above description, the research 
focused on the effects of Tapak Liman (E. scaber 
L) leaf extract on hematopoiesis in female mice 
(Mus muscullus) BALB/c. Expected chemical 
substances contained in extracts of Tapak Liman 
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(E. scaber L) leaves could potentially induce and 
influence the process of hematopoiesis 
differentiation and proliferation, especially on 
lymphopoiesis and erythropoiesis. 
 
MATERIALS AND METHODS 
Preparation of Leaves Extract and Treatment 
The extraction method of Tapak Liman leaves 
was conducted by using sterilized aquades sol-
vent [6,7]. The dried leaves of Tapak Liman 
weighed 13.8 g and mashed by mortar into fine 
powder. Then it dissolved with 100 mL sterilized 
aquades, stirred in 50°C for a night and then 
filtered with filter paper. The results of the 
extract were calcutaed to measure the final 
concentration, and the extract solution is ready 
to be tested. 
Experiment animal used in this study is mice 
(Mus musculus) which randomly sampled from 
an affordable population with criteria included: 
female mice strain BALB/c, 6 weeks old and 
healthy (actively move and intact fur). The ad-
ministration of Tapak Liman (E. scaber L) leaves 
extraxt was given orally. Previously, body weigh 
of the mice was monitored for two weeks. Each 
mice group has the same standard feed and 
drink. The main dependent variable that meas-
ured is the relative number of the cell in 
hematopoiesis phase with following parameters. 
The assessment was only conducted post test, by 
comparing the results of observations in the 
treatment group and control, as well as between 
the treatment groups. 
1. The number of cell population which 
expressed CD4/CD8, CD4/CD62L, TER119/ 
B220 in the spleen 
2. The relative number of cell which expressed 
TER119/B220, TER119/VLA-4, dan TER119/ 
CD34 in the bone marrow 
 
Spleen isolation was done by cut part way of 
the spleen (dark red) with surgical scissors. The 
spleen then washed with PBS and cleaned of 
attached fat. Homogenates were filtered and 
collected in a sterile microtube and stored at a 
temperature of 4°C. 
The bone marrow was obtained from the fe-
mur bone of the left and right legs of mice. Mus-
cles are separated from the femur, both ends of 
the joints were cut with surgical scissors [8].  
Bone marrow was isolated by flushing met-
hod by injecting PBS with 1 ml syringe (26½ ned-
le) at one end of the bone. The results of the in-
jection are accommodated in a sterile petri dish,  
filtered and stored in a sterile microtube, and 
then stored at a temperature of 4°C. 
 
Flowcytometry 
Flowcytometry method used homogenat 
from spleen and bone marrow which is centrifu-
ged at 3200 rpm, 4°C for 2 minutes [9]. Super-
nantant removed  and pelet resuspensed in 1 mL 
of sterilized PBS and then homogenized. Homo-
genat were taken 100-200 L by using micropipet 
and inserted into new steril microtube which 
covered with aluminium foil. Homogenat recentr-
fuged in 3200 rpm, 4°C for 2 minutes, then su-
pernatant removed and microtube put into the 
ice box.  
Pelet in the microtube was added by antibody 
BD BioscienceTM  DC4 FITC  anti mouse conjuga-
ted  and PE-CD8, DC4  FITC anti mouse conjuga-
ted  dan PE-CD62L,  as well as BD BioscienceTM 
antimouse TER-199/Erytrocyt Cell FITC conjuga-
ted  and PE- B220,  for pelet which isolated from 
spleen. While pelet from bone marrow was ad-
ded by antibody BD Bioscienceantimouse TER-
199/ Erytrocyt Cell FITC conjugated  PE- B220, 
TER-199/ Erytrocyt Cell  FITC conjugated  
CD49d/(VLA-4), and  antimouse TER-199/ Erytro-
cyt Cell FITC conjugated  PE-CD34 and then incu-
bated for 15 minutes.  
Next step is connected the computer and  
flowcytometry in the condition Acquiring and 
setting program on computer according expected 
parameters, include setting instrument (Detector, 
Treshold, and Compensation) on the number of 
cells which will be analysed (Acquisition and sto-
rage), label of antibody and laser excitation po-
wer, simple name and determine the grated area 
(R1) on the plot of histogram. Setting plot on 
Aquiring mode, according to the label of antibody 
on the axis of Y and X (FITC or PE) and grating 
area (G1=R1). Flowcytometry was ensured in the 
set of Low-Run. After the instrument ready, pelet  
whaich has been added with antibody  put into 
the kuvet of flowcytometry by micropipet, then 
added 1000 L of steril PBS and homogenized by 
pipetting. Kuvet attached into nozzle BD Bios-
cience FACS Calibur
TM 
flowcytometry and pressed 
acquire panel on the aquisition control. Data 
from flowcytometry was processed with software 
BD CellQuest ProTM and displayed in the form of a 
histogram. 
 
 
 
Data Analysis 
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Quantitative data include the relative number 
of progenitor and precursor cells in the develop-
ment of lymphoid and erythroid of bone marrow 
and spleen which obtained from flowcytometer. 
Data were statistically analysed by normality test 
and variant homogenity test. Data which has 
been distributed with homogeneous variance,  
test by one way ANOVA with = 0.05. If  p value 
0.05 then there is no significant differences, 
whereas if the p value 0.05 then there is 
significant differences between treatments. Last, 
the different group was determined by  post hoc-
test with uji Turkey HSD (High Significant 
Difference). Data analysis was processed by using 
program SPSS 13 for Windows. 
 
RESULTS  
Profile of Cell Express CD4 and CD8 Molecules in 
Spleen 
CD4 is an expressed antigen by inflammation 
T cells, monocyte cells, and macrophage cells 
with function as co-receptor molecules of MHC 
Class II, and receptor for HIV. Otherwise, CD8 is 
an expressed antigen by a subset of thymocytes, 
cytotoxic T cells,  and has functioned as co-
receptor of MHC Class I [10]. 
Flowcytometer analysis found that in the 
spleen (Fig. 1), there are no significant differenc-
es between cells that expressed CD8+CD4, 
CD4
+
CD8
-
, and CD4
+
CD8
+ 
on each group, compa-
red to the control. It indicates that the tretament 
with Tapak Liman on doses 1, 2 and 3 was not 
stimulated the hematopoietic stem cell  (HSC) to 
differentiate spesifically into cells of CD4+CD8-, 
CD4-CD8+, and CD4+CD8+ (p>0.05). 
The number of cell population of CD4+CD8- 
and cell of CD4-CD8+ on treatment P2 (treatment 
1g.g bw
-1
.day
-1
) increased, compared to control 
(Fig. 1). This can be explained that the P2 increa-
sed the total number of cells isolated from sple-
en. We assumed that it happened due to several 
factors. First, the concentration of leaves extract 
of Tapak Liman at dose P2 increase the lymphocy-
tes proliferation; second, population of P2 expo-
sured to the disease; Last, the population of P2 
has a bigger spleen (splenomegaly), i.e. the sple-
en ability to get and keep the erythrocytes will be 
increased. Splenomegaly caused the decrease of 
erythrocytes, leukocytes, and trombocytes in the 
blood circulation.  
Figure 1 describes the number of population T 
cell CD4+ and CD8+ increased on P2 (1 g.g bw.
-1), 
for 7.92 x 106 calls and 8.712 x 106 cells, consecu-
tively. Otherwise, the number of T cell CD4+ and 
CD8+ tend to decrease on treatment P3. It is ex-
pexted du to the negative feedback from the 
administration of Tapak Liman leaves extract. 
Low dose treatment will stimulate the prolifera-
tion of T cell, while contrastly the high doses will 
prevent the proliferation of T cell. It is caused by 
the abundant compound of lupeol and flavanoid 
in the extract of Tapak Liman as anti inflamma-
tion. The phenomenon is in accordance with the 
previous study which mentioned that the effect 
of herbal medicine will stimulate or conversely 
suppress the degree of immunity [11].  
 
 
Figure 1.  Profile of T Cell CD4 and CD8; the number of 
cell expression  CD4+CD8-, CD4+CD8+ and 
CD4+CD8+ in spleen. Description: Control (K), 
Treatment 1 (P1: 0.5 g.g bw.
-1), Treatment 2 (P2: 
1.0 g.g bw.-1), Treatment 3 (P3: 2.0 g.g bw.
-1).    
 
Profile of Cell Express CD4 and CD62L Molecules 
in Spleen  
CD62L is an antigen expressed by B cell, T cell, 
monocyte and Natural Killer Cell (NK cell). It bind 
CD34 which functioned as leukocyte adhesion  
molecule (LAM/L-selectin), GlyCAM, and has ro-
les in the interaction of rolling with endotel [3]. 
The flowcytometer analysis (Fig. 2) showed 
that the treatment group has an average percen-
tage of cell that expresses CD4+CD62L and 
CD4+CD62L+ cells with no significant differences 
for all treatment (p>0.05). Whereas the average 
percentage of cell that express CD4CD62L+ (B 
cell)  increase on the treatment P1 and P2, each 
for 6% and 3% respectively, and tend to decrease 
on treatment P3 for 5%, compared to control. 
Statistical analysis showed a significant effect 
(p<0.05) towards the increased percentage of 
CD62L on treatment P2 (1 g.g bw
-1.day-1). It indi-
cates that the flavonoid compound has an 
increasing effect in the production of IL-2, thus 
increase the B lymphocytes. 
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The number of cell population that express 
CD4+CD62L, CD4CD62L+,  and CD4+CD62L+ on 
treatment (Fig. 2) showed that the highest num-
ber of cell population expression CD4+CD62L and 
CD4CD62L+ is in treatment P2 for 7.128 x 10
6 
cells and 7.524 x 106 cells respectively, compared 
to other treatment and control.  It indicates that 
there is increasing in the cell number that expre-
ss CD4+CD62L (CD4+ T Cell) and CD4CD62L+. 
With the increased doses of Tapak Liman leaves 
extract usage, but tend to decreased cell number 
found in the treatment group of mice P3. The 
number of cells that express the highest 
CD4+CD62L+ in P3 (2.270667 x 10
6 cells)  compa-
red to control. 
 
 
Figure 2.  Profile of CD4 and CD62L cells; relative cell 
number of CD4+CD62L, CD462L+, and CD4+ 
CD62L+ in spleen. Description: Control (K), Tre-
atment 1 (P1: 0.5 g.g bw.
-1), Treatment 2 (P2: 1.0 
g.g bw.-1), Treatment 3 (P3: 2.0 g.g bw.
-1). 
 
Profile of Cell Expres TER119 and B220 in Spleen 
B220 or CD45R antigen is expressed by B cell, 
a subset of T cell (naive T cell), and monocyte. It 
functioned as isoform on A exon-contained CD45 
[10]. Flowcytometer analysis (Fig. 3) showed that 
the given treatment was not affected the 
percentage cell number that expresses TER119+ 
B220 and TER119+B220+. Otherwise, cells that 
express TER119B220+ tend to increase on 
treatment P2 (treatment 1 g.g bw.
-1.day-1) for 9% 
compared to control and decreased for 6% 
compared to treatment P3 (2 g.g bw.
-1.day-1). 
Statistical anaylsis showed that the 
percentage of TER119+B220, TER119B220+  and 
TER119+B220+ were not significantly different 
(p>0.05). Whereas the cell population number of 
TER119+ and B220+  tend to increase on P2 (Fig. 
3), compared to other treatment and control. It 
indicates that flavonoid compound has effects in 
increasing the production of IL-2, thus increase 
the proliferation of B lymphocytes. 
 
Figure 3.  Profile of TER119 and B220 cells; relative cell 
number of TER119+ B220, TER119B220+ and 
TER119+B220+ in the spleen. Description: Con-
trol (K), Treatment 1 (P1: 0.5 g.g bw.
-1), Treat-
ment 2 (P2: 1.0 g.gbw.
-1), Treatment 3 (P3: 2.0 
g.g bw.-1). 
   
Profile of Cell Express TER119 and B220 
Molecules in Bone Marrow 
Bone marrow is the primary or central lym-
phoid organs where the process of hematopoie-
sis occurred. It includes the lymphopoeisis for 
maturation, differentiation and proliferation of T 
cell and B cell into lymphocytes that recognize 
the antigen. Bone marrow also where the 
erythropoiesis (the red blood cells production) 
take places.  
In this study, isolated cells from the bone 
marrow which added with antibody antimouse 
TER-119/Erytrocyt Cell conjugated to FITC 
danantimouse B220 which conjugated to PE (BD 
Bioscience©. TER-119 is a marker on the 
erythroid development in erythropoiesis from 
proerythro-blast to mature erythrocyes. Other-
wise, B220 (CD45) is a molecular marker of B cell 
and all hematopoietic cells which function for 
phosphatase thyroxine, increase signal through 
the antigen receptor of B and T cells.   
Flowcytometer analysis (Fig. 4) showed the 
difference on the average percentage of B220
+ 
(CD45) between treatment group compared to 
control. Percentage of cells that expressed 
TER119B220+ tend to increase on treatment P1 
for 9%, while on the treatment P2, the population 
is significantly increased by 16% compared to 
control. Otherwise, the number of cell population 
TER119+B220 on each individual is not signifi-
cantky different, similar to TER119
+
B220
+
. Refer 
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to these data, the administration of doses on the 
Tapak Liman leaves extract indicates the increas-
ing number of B cell population (B220+/CD45+). 
 
Figure 4. Profile of TER119  and B220 cells; relative cell 
number of TER119+B220, TER119B220+ and 
TER119+ B220+ in bone marrow. Description: 
Control (K), Treatment 1 (P1: 0.5 g.g bw.
-1), Tre-
atment 2 (P2: 1.0 g.g bw.
-1), Treatment 3 (P3: 2.0 
g.gbw.-1).  
 
The highest number of cell population 
TER119B220+ found in P2 (24.546666 x 10
6 cells) 
compared to other treatments. It showed that 
proliferation and differentiation of stem cell 
hematopoietic occurred which tend to the 
production of B cell (B220+/CD45+). The increas-
ing of B cell was assumed due to the flavonoid 
and lupeol compound which contained in Tapak 
Liman.   
 
Profile of Cell Express the TER119 and VLA-4 
Molecules in Bone Marrow 
VLA-4 (Very Late Integrin Antigen-4) or CD49d 
is an antigen expressed by B cell, thymocytes, 
granulocyte and dendritic cell. It functioned as 
integrin a4, connected to CD29 (Leukocytes), 
bind fibronectin, MadCAM-1 and VCAM-1 
(Vacular Adhesion Molecule-1). 
The number of cells that expressed the 
TER119VLA-4+ and TER119+VLA-4+ analysed with 
flowcytometer presented in Figure 5.  Percentage 
of the cells that expressed TER119VLA-4+ was 
decreased for 11% on treatment P2, followed by 
the increase of cell percentage of TER11+VLA-4+ 
for 12%, compared to control. 
Based on Figure 5, the highest cell population 
of TER119+VLA-4+ is in treatment P2, i.e. 7.536 x 
106 cells compared to control. The increased ex-
pression of TER119
+
VLA-4
+ 
on P2 group treatment 
was assumed due to the iron content in Tapak 
Liman which functioned to stimulate the 
progenitor hematopoietc cell to proliferate and 
differentiate into the precursor of erythroid and 
lymphoid into TER119+VLA-4+, which express nuc-
leated erythrocyte cell, and other cells. Besides 
that, the increasing expression of TER119VLA-4+ 
caused by the adhesion molecules interact be-
tween cells with the extracellular matrix which is 
needed I the activation of T cell for leukocytes 
maturation. The increasing of cell number ex-
pressed surface molecules of TER119+ and VLA-
4+. It indicates that the leaves extract of Tapak 
Liman 1 g.g bw.-1day-1 adequate to stimulate the 
proliferation of hematopoietic stem cell on the 
lane of lymphoid and erythroid. It is explained 
that protein VLA on the surface of T cell function 
to channel the activation signal through the T cell 
receptor. On the normal condition leukocyte only 
attach to the endotel cell, but due to the infalm-
mation stimulus, adhesion between leukocyte 
and endotel enhanced [3].  
 
 
Figure 5. Profile of TER119 and LA-4 cells; relative cell 
number of TER119VLA+ and ER119+VLA-4+ cells 
bone marrow. Description: Control (K), Treat-
ment 1 (P1: 0.5 g.g bw.
-1), Treatment 2 (P2: 1.0 
g.gbw.-1), Treatment 3 (P3: 2.0 g.g bw.
-1). 
  
Profile of Cell Express the TER119 and CD34 
Molecules in Bone Marrow 
Cluster of diferentiation 34 (CD34) is an 
antigen expressed by the hematopoietic precur-
sor cell and capillary endothelial cells function as 
Ligand CD62L (L-selectin). Based on the analysis 
of flowcytometer towards the average cell per-
centage of TER119CD34+, TER119+CD34, and 
CD34+TER119+ in the bone marrow presented in 
Figure 6.  
The expression of cell percentage number on 
TER119D34+ was decreased compared to con-
 
 J.Exp. Life Sci. Vol. 5 No. 2, 2015  ISSN. 2087-2852 
  E-ISSN. 2338-1655 
102 Tapak Liman Induced CD4+ & CD8+ Differentiation  
from Hematopoietic Stem Cell of Mice (Djati et al.) 
trol, as well as the percentage of TER119D34+ 
cells. While the cell that expresses CD34+TER119+ 
increased for 4% in treatment P1 and conversely 
tend to decrease on treatment P2 and P3, com-
pared to control.  
 
Figure 6. Profile of TER119 and CD34 cells; relative cell 
number of TER119+CD34+, TER119CD34+ and 
TER119+ CD34+ in bone marrow. Description: 
Control (K), Treatment 1 (P1: 0.5 g.g bw.
-1), Tre-
atment 2 (P2: 1.0 g.gbw.
-1), Treatment 3 (P3: 2.0 
g.g bw.-1).   
 
Based on the absolute number of cell, the 
number of TER119+CD34cell population was not 
increased after being treated with leaves extract 
of Tapak Liman. However, it tends to increase on 
treatment P2, compared to other two treatments.  
Otherwise, the number of TER119CD34+ and 
CD34+TER119+ cell population tend to increase in 
treatment P1 compared to control (Fig. 6). 
Statistical analysis showed no significant dif-
ference (p>0.05) between treatments. It is as-
sumed due to several factors: 1. Method for ex-
traction of active compound was not compatible 
to obtain sufficient active compound from the 
leaves of Tapak Liman (E. scaber L); 2. time of 
samples isolation was not simultaneously. 
 
DISCUSSION 
Based on the study, mice group that given 
with leaves extract of Tapak Liman (E. scaber L) 
for two weeks compared to the control group, 
showed no significant effects towards the 
eryhtropoiesis on female BALB/c mice. It is most 
likely caused by several factors, e.g. extraction 
method of the active compound has not 
appropriate to obtain the active substance from 
the leaves of Tapak Liman (E. scaber L), and the 
different time of extraction. However, the study 
indicates a significant effect on the production of 
B lymphocytes in the bone marrow and the in-
creasing number of B cell (CD62L+) in the spleen. 
The mice group that given the leaves extract 
of Tapak Liman with doses 1 g.g bw.-1day-1 (P2) 
showed the significant effect (p=0.026) towards 
the increasing percentage of cell CD62L+ in the 
spleen and B220+ (p=0.044) in the bone marrow; 
compared to the dose 0.5 and 2 g.g bw.-1day-1, as 
well as the control group for two weeks. It indi-
cates that there was increased proliferation and 
differentiation of the hematopoietic cell into 
lymphocytes, i.e. T cell of CD4+, CD8+, and B220+. 
It is caused by the flavonoid compound that po-
tentialy stimulate the acivity of IL-2, thus increase 
the proliferation of lymphocyte cell.  
Base on the number of cell population from 
all of the treatment groups, it is shown that the 
cell population tends to increase on the addition 
of Tapak Liman leaves extract dose 1 g.g bw.-
1day-1 (P2) compared to the control group. Oth-
erwise, the cell population tends to decrease on 
the treatment dose 2 g.g bw.
-1
day
-1
 (P3). It is ex-
plained that the flavonoid compound, besides 
has the effect of immunostimulant, it also has 
the effect of immunosuppressant [12]. Moreo-
ver, the cytotoxic effects of compounds in Tapak 
Liman which serves as an immunosuppressant 
allow the resistance progenitor cells in the 
lymphoid and erythroid pathway to proliferate 
and differentiate into lymphocytes (lympho-
poiesis) and erythrocytes (erythropoiesis). 
Based on the estimation of cell that expresses 
the TER119+VLA-4+ which identified as the path-
way of the development of erythrocyte 
(erythroid). The increasing cell percentage of 
TER11+VLA-4+ for 12% occurred on treatment P2, 
compared to control. The increased expression of 
TER119
−
VLA-4
+
 is caused by the adhesion mole-
cules interact with the extracellular matrix which 
is needed in the activation of T cell, in the matu-
ration of leukocyte. Furthermore, the increased 
expression of TER119+VLA-4+ assumed due to the 
iron content in Tapak Liman which function  to 
stimulate the progenitor hematopoietic cell to 
proliferate and differentiate into a precursor of 
erythroid (TER119+VLA-4+). It expresses the nuc-
leated erythrocyte cell and other cells. There is 
an increasing number of cell expressed by the 
surface molecules TER119+ and VLA-4+. It indi-
cates that the leaves extract Tapak Liman with 
dose 1 g.g bw.-1day-1 to stimulate the prolifera-
tion of hematopoietic stem cell on the path of 
lymphoid and erythroid.  
 
CONCLUSION 
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The administration of 1 g. g bw
-1
.day
-1 
of the 
extract (P2)  stimulate proliferation of lymphocytes and 
erythrocytes lineage (TER119
+
VLA-4
+
), in spleen and 
bone marrow. 
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